The Beauty Health Company to Release Q4 and Full Year 2025 Financial Results on March 12, 2026

The Beauty Health Company will release Q4 and full year 2025 financial results on March 12, 2026.

Quiver AI Summary

The Beauty Health Company (NASDAQ:SKIN) announced it will release its fourth quarter and full year 2025 financial results on March 12, 2026, after market close. Following the release, the company will hold an investor conference call at 4:30 p.m. Eastern Time, which will be accessible via a live webcast on its investor relations website. A recording of the call will be available shortly after it concludes. The company emphasizes its commitment to transparency by disclosing important information through various channels, including SEC filings and press releases. The Beauty Health Company, widely known for its Hydrafacial brand, offers a range of medical aesthetics solutions aimed at enhancing skin health and supporting providers globally.

Potential Positives

The Beauty Health Company is set to announce its fourth quarter and full year 2025 financial results, which could provide insights into the company’s performance and growth, creating potential investor interest.
The scheduled investor conference call indicates the company's commitment to transparency and communication with shareholders, enhancing investor confidence.
Access to a live webcast of the call and subsequent recording increases accessibility for investors and analysts, fostering greater engagement with the company's activities and performance.
The presence of innovative products such as Hydrafacial™, SkinStylus™, and HydraScalp powered by Keravive™ emphasizes the company's dedication to advanced skincare solutions, potentially attracting new clients and enhancing brand reputation.

Potential Negatives

Announcement of upcoming financial results implies that investors may be anticipating significant news or potential concerns regarding the company's performance.
No financial guidance or expectations are provided ahead of the results, which could indicate uncertainty or instability to investors.
The focus on the company's disclosure methods suggests a need to emphasize transparency, potentially highlighting past concerns about information dissemination or investor communication.

FAQ

When will The Beauty Health Company report its financial results?

The Beauty Health Company will report its fourth quarter and full year 2025 financial results on March 12, 2026.

Where can I access the investor conference call for the financial results?

The investor conference call can be accessed via the Company's investor relations website at https://investors.beautyhealth.com.

What is the flagship brand of The Beauty Health Company?

The flagship brand of The Beauty Health Company is Hydrafacial™.

How can I find local providers of Hydrafacial treatments?

Local providers of Hydrafacial treatments can be found at hydrafacial.com/find-a-hydrafacialist.

What does The Beauty Health Company specialize in?

The Beauty Health Company specializes in global medical aesthetics, offering solutions for superior skin health through advanced treatments.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$SKIN Revenue

$SKIN had revenues of $70.7M in Q3 2025. This is a decrease of -10.34% from the same period in the prior year.

You can track SKIN financials on Quiver Quantitative's SKIN stock page.

$SKIN Hedge Fund Activity

We have seen 54 institutional investors add shares of $SKIN stock to their portfolio, and 65 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MILLENNIUM MANAGEMENT LLC added 3,225,668 shares (+127.0%) to their portfolio in Q4 2025, for an estimated $4,483,678
MIRABELLA FINANCIAL SERVICES LLP added 3,114,986 shares (+20.0%) to their portfolio in Q4 2025, for an estimated $4,329,830
JANUS HENDERSON GROUP PLC removed 2,692,940 shares (-91.3%) from their portfolio in Q4 2025, for an estimated $3,743,186
OWLS NEST PARTNERS IA, LLC removed 1,109,629 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,542,384
SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,990,000
WOODLINE PARTNERS LP removed 610,130 shares (-10.3%) from their portfolio in Q4 2025, for an estimated $848,080
JACOBS LEVY EQUITY MANAGEMENT, INC removed 608,288 shares (-50.2%) from their portfolio in Q4 2025, for an estimated $845,520

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$SKIN Price Targets

Multiple analysts have issued price targets for $SKIN recently. We have seen 3 analysts offer price targets for $SKIN in the last 6 months, with a median target of $1.65.

Here are some recent targets:

Oliver Chen from TD Cowen set a target price of $1.65 on 01/21/2026
Sydney Wagner from Jefferies set a target price of $1.6 on 01/14/2026
George Kelly from Roth Capital set a target price of $3.5 on 09/19/2025

Full Release

LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.

A live webcast of the call can be accessed on the Company’s investor relations website at https://investors.beautyhealth.com , along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion.

Disclosure Information
The Beauty Health Company announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls and on its investor relations website ( https://investors.beautyhealth.com ) as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About Us
The Beauty Health Company (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp powered by Keravive™, BeautyHealth combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at beautyhealth.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist .

Investors: [email protected]
Press: [email protected]